HFX AdaptivAI combines insights from more than 100 million data points and more than 100,000 patients for responsive and personalized pain relief, according to a news release. The spinal cord stimulator provides real-time insights and remote monitoring for physicians.
Nevro plans a full U.S. market release of HFX iQ with HFX AdaptiveAI in the fourth quarter of 2024.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
